 | Up a level |
Journal Article
Ernst, J. B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Knabbe, C., Berthold, H. K., Pilz, S., Gouni-Berthold, I., Gummert, J. F., Boergermann, J. and Zittermann, A. (2017). Randomized supplementation of 4000 IU vitamin D-3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial. Nutr. J., 16. LONDON: BIOMED CENTRAL LTD. ISSN 1475-2891
Gelrud, A. A., Digenio, A., Alexander, V., Williams, K. R., Hsieh, A., Gouni-Berthold, I., Bruckert, E., Stroes, E., Geary, R., Hughes, S., Tsmikas, S., Witztum, J. L. and Gaudet, D. (2017). Treatment With Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients With Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (sHTG) vs Placebo: Results of the Approach and Compass Studies. Pancreas, 46 (10). S. 1402 - 1403. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1536-4828
Gouni-Berthold, I., Alexander, V., Digenio, A., DuFour, R., Steinhagen-Thiessen, E., Martin, S., Moriarty, P., Hughes, S., Jones, R., Witztum, J. L., Gaudet, D. and Stroes, E. (2017). Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): A randomized, double-blind, placebo-controlled trial. Atheroscler. Suppl., 28. S. E1 - 2. CLARE: ELSEVIER IRELAND LTD. ISSN 1878-5050
Gouni-Berthold, I. and Berthold, H. K. (2011). Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases. Curr. Pharm. Design, 17 (33). S. 3690 - 3699. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1873-4286
Gouni-Berthold, I. and Berthold, H. K. (2015). Treatment of Cardiovascular Risk Factors in Women. Curr. Med. Chem., 22 (31). S. 3580 - 3597. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1875-533X
Klose, G., Beil, F. U., Dieplinger, H., von Eckardstein, A., Foeger, B., Gouni-Berthold, I., Heigl, F., Koenig, W., Kostner, G. M., Landmesser, U., Laufs, U., Leistikow, F., Maerz, W., Merkel, M., Mueller-Wieland, D., Noll, G., Parhofer, K. G., Paulweber, B., Riesen, W., Schaefer, J. R., Steinhagen-Thiessen, E., Steinmetz, A., Toplak, H., Wanner, C. and Windler, E. (2014). New AHA- and ACC-Guidelines for Risk Reduction of Cardio-Vascular-Disease by lowering Cholesterol. Measures of the D.A.CH-Prevention Society of Cardio-Vascular-Diseases e.V., the Austrian Atherosclerosis Society and the Study Group of Lipids and Atherosclerosis (AGLA) of the Swiss Society of Cardiology (vol 55, pg 601, 2014). Internist, 55 (9). S. 1112 - 1113. NEW YORK: SPRINGER. ISSN 1432-1289
Klose, G., Beil, F. U., Dieplinger, H., von Eckardstein, A., Foeger, B., Gouni-Berthold, I., Koenig, W., Kostner, G. M., Landmesser, U., Laufs, U., Leistikow, F., Maerz, W., Merkel, M., Mueller-Wieland, D., Noll, G., Parhofer, K. G., Paulweber, B., Riesen, W., Schaefer, J. R., Steinhagen-Thiessen, E., Steinmetz, A., Toplak, H., Wanner, C. and Windler, E. (2014). New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Statement of the D center dot A center dot CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology. Internist, 55 (5). S. 601 - 607. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Pafili, K., Gouni-Berthold, I. and Papanas, N. (2015). Abdominal aortic aneurysms: do not underestimate the role of diabetes. Expert Rev. Cardiovasc. Ther., 13 (12). S. 1289 - 1291. PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 1744-8344
Sever, P. S., Gouni-Berthold, I., Keech, A., Giugliano, R., Pedersen, T., Wasserman, S., Im, K., Sabatine, M. and O'Donoghue, M. (2018). Benefit of LDL-C lowering with evolocumab on cardiovascular outcomes by age & sex: an analysis of the FOURIER trial. Eur. Heart J., 39. S. 1041 - 1043. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Siegmund, S. Aparicio, Garbers, Y., Flynn, C. M., Waetzig, G. H., Gouni-Berthold, I., Krone, W., Berthold, H. K., Rose-John, S. and Garbers, C. (2016). THE INTERLEUKIN-6-NEUTRALIZING SOLUBLE (S)IL-6R/SGP130 BUFFER SYSTEM IS DISTURBED IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Cytokine, 87. S. 138 - 140. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-0023
Stroes, E. S., van der Valk, F. M., Gaudet, D., Gouni-Berthold, I., Riksen, N. P., Steinhagen-Thiessen, E., Isermann, B., Nordestgaard, B., Viney, N. J., Marcovina, S., Hughes, S. G., Tami, J., Xia, S., Witztum, J. L. and Tsimikas, S. (2016). PREVALENCE OF LPA SINGLE NUCLEOTIDE POLYMORPHISMS AND ISOFORMS IN PATIENTS ENROLLED IN A PHASE 2 IONIS-APO(A)(RX) CLINICAL TRIAL. Atherosclerosis, 252. S. E123 - 1. CLARE: ELSEVIER IRELAND LTD. ISSN 1879-1484
Zittermann, A., Ernst, J. B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Berthold, H. K., Pilz, S., Gouni-Berthold, I. and Gummert, J. F. (2018). Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial. Osteoporosis Int., 29 (3). S. 579 - 587. LONDON: SPRINGER LONDON LTD. ISSN 1433-2965